留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

中药活性成分的高通量筛选新技术

丁璇,  洪战英,  柴逸峰

downloadPDF
文章导航 > 药学实践与服务  > 2015 >  33(3): 193-197
丁璇, 洪战英, 柴逸峰. 中药活性成分的高通量筛选新技术[J]. 药学实践与服务, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
引用本文: 丁璇, 洪战英, 柴逸峰. 中药活性成分的高通量筛选新技术[J]. 药学实践与服务, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
shu
DING Xuan, HONG Zhanying, CHAI Yifeng. New technologies for high throughput screening of effective traditional Chinese medicine components[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
Citation: DING Xuan, HONG Zhanying, CHAI Yifeng. New technologies for high throughput screening of effective traditional Chinese medicine components[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
shu

中药活性成分的高通量筛选新技术

doi: 10.3969/j.issn.1006-0111.2015.03.001

  • 第二军医大学药学院, 上海 200433

New technologies for high throughput screening of effective traditional Chinese medicine components

  • School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 摘要: 以近年来国内外研究文献为基础, 总结概括了近5年来中药活性成分的高通量筛选新技术的进展情况。其中生物色谱技术、芯片技术和计算机辅助虚拟筛选等技术得到了广泛应用。这些新技术在中药活性成分筛选方面, 比起传统方法具有效率高、自动化、通量高的优点, 可以为中药活性成分的高通量筛选提供新思路。
    Abstract: The research progress on new technologies for high throughput screening of effective traditional Chinese medicine (TCM) components was summarized based on the recent documents at home and abroad, among which bio-chromatography, chip-technology and computer-aided virtual screen technology were widely used. Compared with traditional screening technology, those new ones had shown advantages in efficiency, automation and high-throughput, providing new ways to screen effective components of TCM with high throughput.
  • [1] Wong KC, Wu L.History of Chinese medicine. Being a chronicle of medical happenings in China from ancient times to the present period[J].Nature, 1933, 4(5):527-529.
    [2] Bent S.Herbal medicine in the United States: review of efficacy, safety, and regulation[J].J Gen Intern Med, 2008, 23(6): 854-859.
    [3] Yeh GY, Eisenberg DM, Kaptchuk TJ.Systematic review of herbs and dietary supplements for glycemic control in diabetes[J].Diabetes Care, 2003, 26(4): 1277-1294.
    [4] Hopkins AL.Network pharmacology: the next paradigm in drug discovery[J].Nat Chem Biol, 2008, 4(11): 682-690.
    [5] Chen C,Yang FQ, Zuo H, et al. Applications of biochromatography in the screening of bioactive natural products[J].J Chroma Sci, 2013, 51(8): 780-790.
    [6] Luo H, Chen L, Li Z,et al.Frontal immunoaffinity chromatography with mass spectrometric detection:a method for finding active compounds from traditional Chinese herbs[J].Anal Chem, 2003, 75(16): 3994-3998.
    [7] Zhao X, Li Q, Bian L,et al.Using immobilized G-protein coupled receptors to screen bioactive traditional Chinese medicine compounds with multiple targets[J].J Pharm Biomed Anal, 2012, 70: 549-552.
    [8] Wang B, Deng J, Gao Y,et al.The screening toolbox of bioactive substances from natural products: a review[J].Fitoterapia, 2011, 82(8): 1141-1151.
    [9] Wang L,Ren J,Sun M,et al.A combined cell membrane chromatography and online HPLC/MS method for screening compounds from Radix Caulophylli acting on the human α1A-adrenoceptor[J]. J Pharm Biomed Anal,2010,51(5):1032-1036.
    [10] Zhang T, Han S, Huang J,et al.Combined fibroblast growth factor receptor 4 cell membrane chromatography online with high performance liquid chromatography/mass spectrometry to screen active compounds in Brassica albla[J].J Chromatogr B, 2013, 912: 85-92.
    [11] Yue Y, Xue H, Wang X.High-expression β1 adrenergic receptor/cell membrane chromatography method based on a target receptor to screen active ingredients from traditional Chinese medicines[J].J Sep Sci, 2014, 37(3): 244-249.
    [12] Chen X, Cao Y, Lv D, et al.Comprehensive two-dimensional HepG2/cell membrane chromatography/monolithic column/time of flight mass spectrometry system for screening anti-tumor components from herbal medicines[J].J Chromatogr A, 2012, 1242: 67-74.
    [13] Yakufu P, Qi H, Li M,et al.CCR4 expressing cells cultured adherently on a capillary wall and formaldehyde fixed as the stationary phase for ligand screening by ACE[J].Electrophoresis, 2013, 34(4): 531-540.
    [14] Woo CSJ, Lau JSH, El-Nezami H,et al.Herbal medicine: toxicity and recent trends in assessing their potential toxic effects[J].Adv Bot Res, 2012, 62: 365-384.
    [15] Ye F, Wang H, Jiang S,et al.Quality evaluation of commercial extracts of scutellaria baicalensis[J].Nutr Cancer, 2004, 49(2): 217-222.
    [16] Ren G, Fan X, Liang Q,et al.Screening and evaluation of traditional Chinese medicine by microarray expression analysis[J].J Ethnopharmacol, 2013, 147(3): 564-569.
    [17] Liu M, Fan J, Wang S,et al.Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity[J].BMC Complement Altern Med, 2013, 13: 11-29.
    [18] Song YN, Zhang H, Guan Y,et al.Classification of traditional Chinese medicine syndromes in patients with chronic hepatitis B by SELDI-Based proteinchip analysis[J].Evid Based Complement Alternat Med, 2012,2012:626320.
    [19] Yao L, Dong W, Lu F,et al.An improved acute gouty arthritis rat model and therapeutic effect of Rhizoma dioscoreae nipponicae on acute gouty arthritis based on the protein-chip methods[J].Am J Chin Med, 2012, 40(1): 121-134.
    [20] Carr JA, Parashar A, Gibson R,et al.A microfluidic platform for high-sensitivity, real-time drug screening on C. elegans and parasitic nematodes[J].Lab Chip, 2011, 11(14): 2385-2396.
    [21] Sandoz A, Charvet I, Stoppini L,et al.Development of a microfluidic biochip for chronic monitoring of 3D neural tissues derived from human embryonic stem cells[J].Procedia Eng, 2013, 59: 46-50.
    [22] Behr J.The Lock-and-Key principle, the state of the art-100 years on[M].Chichester:Wiley, 1995: 1-336.
    [23] Hansch C.Quantitative approach to biochemical structure-activity relationships[J].Accounts Chem Res, 1969, 2(8): 232-239.
    [24] Ge H, Wang Y, Li C,et al.Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing[J].J Chem Inf Model, 2013, 53(10): 2757-2764.
    [25] Lyne PD.Structure-based virtual screening: an overview[J].Drug Discov Today, 2002, 7(20): 1047-1055.
    [26] Irwin JJ, Shoichet BK.ZINC-a free database of commercially available compounds for virtual screening[J].J Chem Inf Model, 2005, 45(1): 177-182.
    [27] Chan AH, Wereszczynski J, Amer BR,et al. Discovery of Staphylococcus aureus sortase a inhibitors using virtual screening and the relaxed complex scheme[J].Chem Biol Drug Des, 2013, 82(4): 418-428.
    [28] Barlow DJ, Buriani A, Ehrman T,et al.In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date[J].J Ethnopharmacol, 2012, 140(3): 526-534.
    [29] Pitt WR, Calmiano MD, Kroeplien B,et al. Structure-based virtual screening for novel ligands[J]. Methods Mol Biol, 2013,1008: 501-519.
    [30] Ellingson SR, Dakshanamurthy S, Brown M,et al.Accelerating virtual high-throughput ligand docking: current technology and case study on a petascale supercomputer[J].Concurr Comp Pract E, 2013,26:1268-1277.
    [31] Lavecchia A, Di Giovanni C.Virtual screening strategies in drug discovery: acritical review[J].Curr Med Chem, 2013, 20(23): 2839-2860.
    [32] Karthick V, Ramanathan K.Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach[J].Springer Plus, 2013, 2(1): 115-124.
    [33] Tian S, Sun H, Li Y,et al. Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures[J].J Chem Inf Model, 2013, 53(10): 2743-2756.
    [34] Berger WT, Ralph BP, Kaczocha M,et al.Targeting fatty acid binding protein (FABP) anandamide transporters-a novel strategy for development of anti-inflammatory and anti-nociceptive drugs[J].PLos One, 2012, 7(12): e50968.
    [35] Wang E, Bussom S, Chen J,et al.Interaction of a traditional Chinese medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment[J].BMC Med Genomics, 2011, 4(1): 38-50.
  • [1] 韩健勇, 蒋益萍, 韩婷, 辛海量.  防疫中药大健康产品概述及展望 . 药学实践与服务, 2022, 40(5): 433-436, 441. doi: 10.12206/j.issn.2097-2024.202103015
    [2] 权丹妮, 徐玥, 曲卓, 许维恒, 张万年, 庄春林.  宁夏苦豆子主要活性成分及治疗肝脏疾病的研究进展 . 药学实践与服务, 2022, 40(1): 1-5, 37. doi: 10.12206/j.issn.1006-0111.202105035
    [3] 柴心怡, 顾妍秋, 陈啸飞, 柴逸峰.  新型生物色谱固定相制备及分析方法学研究进展 . 药学实践与服务, 2022, 40(3): 193-198. doi: 10.12206/j.issn.1006-0111.202112087
    [4] 余亚茹, 鲁鹏飞, 王红霞, 黄宝康.  中药防治新型冠状病毒肺炎概述 . 药学实践与服务, 2020, 38(3): 202-206, 210. doi: 10.12206/j.issn.1006-0111.202003098
    [5] 孟鸽飞, 柴蓉蓉, 丁佳宁, 朱聪聪, 朱全刚.  中药凝胶贴膏基质处方的研究进展 . 药学实践与服务, 2018, 36(6): 484-487,498. doi: 10.3969/j.issn.1006-0111.2018.06.002
    [6] 张敏新, 曾棋平, 宋洪涛.  中药制剂防潮技术研究进展 . 药学实践与服务, 2016, 34(1): 16-18. doi: 10.3969/j.issn.1006-0111.2016.01.005
    [7] 卞俊.  南蛇藤活性成分及药理作用研究概况 . 药学实践与服务, 2015, 33(3): 201-204,220. doi: 10.3969/j.issn.1006-0111.2015.03.003
    [8] 季晓, 宣槐斌, 黄宝康.  明党参活性成分及药理作用研究进展 . 药学实践与服务, 2015, 33(2): 102-105,137. doi: 10.3969/j.issn.1006-0111.2015.02.002
    [9] 金乾兴, 周峰.  抗乙型肝炎病毒中药活性成分研究进展 . 药学实践与服务, 2012, 30(2): 96-99,148. doi: 10.3969/j.issn.1006-0111.2012.02.005
    [10] 腾海英, 曲丽萍, 李晓林, 张明媛, 亓云鹏.  气相色谱-质谱结合化学计量学方法分析中药挥发油成分的研究进展 . 药学实践与服务, 2010, 28(4): 245-247,295.
    [11] 汪涛, 孙亮, 梁蓉梅, 宓鹤鸣.  中药超微粉碎的研究进展与应用前景 . 药学实践与服务, 2007, (3): 129-133.
    [12] 王晓红.  中药调节血脂研究概况 . 药学实践与服务, 2007, (2): 73-77.
    [13] 郑成, 向智敏.  液相色谱-质谱联用法检出降糖胶囊中的格列本脲和苯乙双胍 . 药学实践与服务, 2007, (6): 388-390.
    [14] 黄宝康, 秦路平.  药用植物内生菌的生物多样性及活性成分 . 药学实践与服务, 2006, (4): 193-196.
    [15] 黄晟, 谷莉, 黄河舟, 柴逸峰.  中药色谱指纹图谱研究进展 . 药学实践与服务, 2003, (6): 326-329.
    [16] 梁毅, 杜文清.  我国中药如何进入国际市场的分析研究 . 药学实践与服务, 2001, (1): 35-38,34.
    [17] 徐爱军, 赵万洲, 申俊龙.  我国中药出口存在问题及相应策略 . 药学实践与服务, 1998, (5): 257-260.
    [18] 李润平, 王原, 高玮, 李祥军, 张汉明.  当归等中药及其主要成分对高压氧致急性氧中毒预防作用的实验研究 . 药学实践与服务, 1998, (5): 263-264.
    [19] 赵芝兰, 陆峰, 吴玉田.  智能多柱高效液相色谱系统及其在中药质量控制中的应用 . 药学实践与服务, 1998, (2): 97-100.
    [20] 杜青云, 潘冬林, 茆瑜.  73例急性中药中毒分析 . 药学实践与服务, 1995, (5): 277-279.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  5600
  • HTML全文浏览量:  1114
  • PDF下载量:  985
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-02-21
  • 修回日期:  2014-07-18

中药活性成分的高通量筛选新技术

doi: 10.3969/j.issn.1006-0111.2015.03.001
  • 第二军医大学药学院, 上海 200433
  • 收稿日期: 2014-02-21
  • 修回日期: 2014-07-18

摘要: 以近年来国内外研究文献为基础, 总结概括了近5年来中药活性成分的高通量筛选新技术的进展情况。其中生物色谱技术、芯片技术和计算机辅助虚拟筛选等技术得到了广泛应用。这些新技术在中药活性成分筛选方面, 比起传统方法具有效率高、自动化、通量高的优点, 可以为中药活性成分的高通量筛选提供新思路。

English Abstract

丁璇, 洪战英, 柴逸峰. 中药活性成分的高通量筛选新技术[J]. 药学实践与服务, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
引用本文: 丁璇, 洪战英, 柴逸峰. 中药活性成分的高通量筛选新技术[J]. 药学实践与服务, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
shu
DING Xuan, HONG Zhanying, CHAI Yifeng. New technologies for high throughput screening of effective traditional Chinese medicine components[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
Citation: DING Xuan, HONG Zhanying, CHAI Yifeng. New technologies for high throughput screening of effective traditional Chinese medicine components[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 193-197. doi: 10.3969/j.issn.1006-0111.2015.03.001
shu

    全文HTML

参考文献 (35)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计